Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperparathyroidism--new aspects].

A Kruse1, J Beige

  • 1Klinik und Poliklinik für Nephrologie und Hypertonie, Universitätsspital, Bern.

Therapeutische Umschau. Revue Therapeutique
|August 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of sequential HTC pre-treatment and pyrolysis on wet food-industry wastes: Optimisation toward nitrogen-rich hierarchical carbonaceous materials intended for use in energy storage solutions.

The Science of the total environment·2021
Same author

Understanding glomerular diseases through proteomics.

Expert review of proteomics·2021
Same author

[Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].

Der Internist·2020
Same author

Valorization of the poultry litter through wet torrefaction and different activation treatments.

The Science of the total environment·2020
Same author

Research on the care of people with dementia in acute care hospital settings : Opportunities, challenges and limitations.

Zeitschrift fur Gerontologie und Geriatrie·2019
Same author

[Dignity, freedom, embodiment : Ethical categories concerning the use of freedom-depriving measures in people with dementia in acute care settings].

Zeitschrift fur Gerontologie und Geriatrie·2019
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Primary and secondary hyperparathyroidism have distinct causes and treatments. Primary hyperparathyroidism often requires surgery, while secondary hyperparathyroidism may be managed with vitamin D or calcium-sensing receptor therapies.

Area of Science:

  • Endocrinology
  • Nephrology

Context:

  • Hyperparathyroidism presents as primary or secondary forms.
  • Primary hyperparathyroidism involves autonomous parathyroid gland overactivity.
  • Secondary hyperparathyroidism is often linked to vitamin D deficiency or kidney failure.

Purpose:

  • To differentiate between primary and secondary hyperparathyroidism.
  • To outline the distinct pathophysiological mechanisms of each form.
  • To describe current therapeutic strategies.

Summary:

  • Primary hyperparathyroidism, caused by adenomatous hypertrophy/hyperplasia, leads to elevated parathyroid hormone (PTH), hypercalcemia, and symptoms like fatigue and calcinosis.
  • Secondary hyperparathyroidism, often due to vitamin D deficiency or kidney failure, involves increased PTH secretion to maintain calcium homeostasis, alongside parathyroid hyperplasia.

Related Experiment Videos

  • Therapeutic approaches vary: surgery is key for primary and late secondary forms, while early secondary hyperparathyroidism benefits from vitamin D supplementation or calcium-sensing receptor sensitizers.

    • Impact:

    • Clarifies diagnostic and therapeutic distinctions between hyperparathyroidism subtypes.
    • Informs clinical management strategies for diverse patient populations.
    • Highlights the importance of addressing underlying causes like vitamin D deficiency and kidney disease.